BofA Finance LLC, a subsidiary of Bank of America Corporation, has filed a preliminary pricing supplement disclosing plans to offer Enhanced Return Notes linked to the least performing of the Nasdaq-100 Futures Excess Return Index and the S&P 500 Futures Excess Return Index, with an expected pricing date of July 15, 2026 and an expected issue date of July 20, 2026. The structured notes carry an approximate seven-year term, maturing on July 20, 2033, and are fully and unconditionally guaranteed by Bank of America Corporation. The product offers investors a 355.00% upside participation rate on gains in the least performing of the two underlying indexes at maturity, while also exposing investors to potential loss of up to 100% of principal if either underlying index declines more than 35% from its starting value. Investors tracking NASDAQ: MER-PK and related Bank of America structured products may wish to closely review the terms, risk factors, and initial estimated value disclosed in the preliminary supplement.
Key Points
- NASDAQ: MER-PK — issuer BofA Finance LLC, guaranteed by Bank of America Corporation (BAC)
- Enhanced Return Notes expected to price on July 15, 2026, and issue on July 20, 2026, with a maturity date of July 20, 2033
- Upside Participation Rate of 355.00% applies if both underlyings finish above their respective starting values; principal is at full risk if either underlying falls more than 35% from its starting value
- Initial estimated value disclosed at between $891.30 and $961.30 per $1,000.00 in principal amount — below the $1,000.00 public offering price
Structure of the Enhanced Return Notes and the Two Underlying Indexes
The Notes are linked to the performance of two specific indexes: the Nasdaq-100 Futures Excess Return Index, identified by Bloomberg symbol "NDXNQER," and the S&P 500 Futures Excess Return Index, identified by Bloomberg symbol "SPXFP." Payment at maturity is determined by whichever of these two indexes performs least favorably over the approximately seven-year investment period, a structure commonly referred to as a "worst-of" or "least performing" design. This construction means that even if one index appreciates significantly, the payout is anchored entirely to the index that performs worse.
The Notes will be issued in minimum denominations of $1,000.00, with additional purchases available in whole multiples of $1,000.00. The filing states that the Notes will not be listed on any securities exchange, meaning there is no organized secondary market through which investors can readily sell the Notes after issuance. CUSIP number 09712G6M1 has been assigned to the Notes, and BofA Securities, Inc., an affiliate of BofA Finance, has been named both as the Calculation Agent and the Selling Agent for the offering.
How the 355% Upside Participation Rate Works at Maturity
The filing discloses that investors stand to receive 355.00% exposure to increases in the value of the Least Performing Underlying, provided that the ending value of each underlying is greater than 100% of its respective starting value at the valuation date of July 15, 2033. This enhanced participation rate represents the primary return mechanism intended to attract investors to the product in exchange for accepting the principal risk and the absence of periodic interest payments during the seven-year term.
The starting value for each underlying is defined as its closing level on the pricing date, and the ending value is its closing level on the valuation date of July 15, 2033. If the least performing underlying ends precisely at or between its starting value and its threshold value — that is, it has not gained but has also not fallen more than 35% — the filing states that investors will receive the principal amount of $1,000.00 per note. The upside participation benefit is therefore forfeited if either underlying fails to finish in positive territory, even if one of the two indexes posts strong gains.
Principal Protection Threshold and Downside Exposure Explained
A central risk feature of the Notes is the threshold value mechanism. The threshold value for each underlying is set at 65.00% of its starting value, meaning that principal is fully returned at maturity only if neither underlying has declined by more than 35% from its starting level on the pricing date. The filing is explicit that if either underlying falls below its threshold value, the investor's redemption amount will be calculated on a 1:1 basis relative to the decline in the least performing underlying, with no floor protection below that threshold.
The disclosure states clearly that in the scenario where either underlying breaches its threshold, "the Redemption Amount will be less than 65.00% of the principal amount and you could lose up to 100.00% of your investment in the Notes." This is a material risk that distinguishes the Notes from conventional fixed-income instruments. There is no guaranteed minimum repayment once the barrier is breached, and the Notes carry no FDIC insurance, no bank guarantee, and may lose value, as explicitly stated on the cover page of the pricing supplement.
Initial Estimated Value Below Public Offering Price: What the Discount Means
The preliminary pricing supplement discloses that the initial estimated value of the Notes as of the pricing date is expected to be between $891.30 and $961.30 per $1,000.00 in principal amount. This means that on the day of purchase, investors who pay the full public offering price of $1,000.00 per note are effectively paying a premium above the issuer's own estimated fair value of the instrument, with the gap ranging from approximately $38.70 to $108.70 per note depending on where within the estimated range the final value falls.
The filing explains that this gap exists because the economic terms of the Notes are based on Bank of America Corporation's internal funding rate — which is typically lower than the rate it would pay on conventional fixed or floating rate debt — as well as the underwriting discount and hedging-related charges. The filing notes that the underwriting discount per $1,000.00 in principal amount may be as high as $2.50, resulting in proceeds to BofA Finance of as low as $997.50 per note before expenses. The final pricing supplement will set forth the precise initial estimated value as of the pricing date.
Credit Risk of BofA Finance and the Bank of America Guarantee
Any payment on the Notes is expressly subject to the credit risk of BofA Finance LLC as issuer and Bank of America Corporation as guarantor. The filing makes clear that all redemption amounts, whether at maturity or upon any acceleration event, are contingent on the financial capacity of both entities to meet their obligations. Bank of America Corporation provides a full and unconditional guarantee of BofA Finance's obligations under the Notes, which is intended to support investor confidence in the issuer's ability to pay.
The filing also describes what occurs in the event of a default or acceleration. If an event of default occurs and is continuing, the amount payable to a holder upon any permitted acceleration will be equal to the redemption amount calculated as though the date of acceleration were the maturity date, with the valuation date treated as the third trading day prior to the date of acceleration. The filing also specifies that in the case of a default in payment, the Notes will not bear a default interest rate, which is a departure from how some conventional debt instruments treat defaults.
No Periodic Interest Payments and the Fee-Based Advisory Account Pricing Consideration
The Notes do not pay any periodic interest during the approximately seven-year term. This is a defining structural characteristic of the product, and the absence of coupons means that the entire return to investors — if any — is delivered solely through the lump-sum redemption amount at maturity. Investors accustomed to receiving regular income from fixed-income instruments should note that this product does not provide that feature, and the return profile is entirely contingent on index performance over the full term.
For investors purchasing through fee-based advisory accounts, the filing states that certain dealers may forgo some or all of their selling concessions, fees, or commissions. In those cases, the public offering price may be as low as $997.50 per $1,000.00 in principal amount. This provision reflects the broader trend in structured product distribution where fee-based advisors who charge clients separately for advice may receive notes at a reduced price compared to the standard public offering price.
Valuation Date, Maturity Date, and Postponement Provisions
The valuation date for the Notes is scheduled for July 15, 2033, and the maturity date is set for July 20, 2033. However, the filing states that the valuation date is "subject to postponement as described under 'Description of the Notes — Certain Terms of the Notes — Events Relating to Calculation Days' in the accompanying product supplement." This provision acknowledges that market disruptions or other events affecting the calculation of index closing levels could result in the valuation date being pushed back, which in turn could affect the maturity date.
Both the pricing date of July 15, 2026, and the issue date of July 20, 2026, are noted in the filing as subject to change. Investors should be aware that all key dates carry this caveat and should consult the final pricing supplement once it is published, as the final document will contain the confirmed pricing date, starting values for each underlying, and the confirmed initial estimated value of the Notes. The preliminary nature of this supplement means that certain terms remain subject to revision prior to final issuance.
Registration Statement and Prospectus Documentation Framework
The Notes are offered pursuant to an effective Registration Statement under the Securities Act of 1933, with Registration Statement numbers 333-290665 and 333-290665-01. The preliminary pricing supplement is accompanied by a Product Supplement (EQUITY-1 dated December 8, 2025), a Series A Prospectus Supplement dated December 8, 2025, and a Prospectus dated December 8, 2025. Together, these documents form the complete disclosure framework governing the terms and conditions of the Notes.
The filing references risk factors disclosed across multiple sections of the broader documentation package, noting that potential purchasers should review risk factor disclosures beginning on page PS-6 of the pricing supplement, page PS-3 of the accompanying product supplement, page S-7 of the accompanying prospectus supplement, and page 7 of the accompanying prospectus. The breadth of the risk factor disclosure across multiple documents underscores the complexity of the product and the range of scenarios under which investors could experience outcomes that differ significantly from their expectations at the time of purchase.
Preliminary Nature of the Supplement and Investor Considerations
The cover page of the filing explicitly states that the pricing supplement "is not complete and may be changed," and that it "relates to an effective Registration Statement under the Securities Act of 1933." It further clarifies that neither the supplement nor the accompanying documents constitute an offer to sell the Notes in any jurisdiction where such an offer would not be permitted. These disclosures are standard for preliminary pricing supplements filed ahead of a structured note offering, and the final terms will be established on the pricing date.
Investors considering participation in this offering are directed by the filing to review the full suite of accompanying documentation, including the product supplement and prospectus, before making any investment decision. The filing itself notes important differences between the Notes and a conventional debt security, and emphasizes that the actual value of the Notes at any time following issuance will reflect many factors and cannot be predicted with accuracy. The immediate share price impact on any related securities was not clear from available public information at the time of this report.





Please wait processing your request...